France
# |
Name |
Shares (Diluted, Weighted) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
95,121,390
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
2 |
80,453,282
|
Dec. 31, 2023 | USD 2.09 | 3.97% |
|
France |
|
3 |
70,626,248
|
Dec. 31, 2023 | USD 0.63 | -3.60% |
|
France |
|
4 |
68,199,880
|
Dec. 31, 2023 | USD 1.64 | -0.17% |
|
France |
|
5 |
49,700,223
|
Dec. 31, 2023 | USD 3.95 | 0.89% |
|
France |
|
6 |
45,351,799
|
Dec. 31, 2023 | USD 2.40 | -1.45% |
|
France |
|
7 |
43,066,012
|
Dec. 31, 2023 | USD 6.04 | 2.29% |
|
France |
|
8 |
38,159,930
|
Dec. 31, 2023 | USD 1.97 | -2.73% |
|
France |
|
9 |
36,928,161
|
Dec. 31, 2023 | USD 3.58 | 3.12% |
|
France |
|
10 |
29,091,656
|
Dec. 31, 2023 | USD 1.42 | -1.61% |
|
France |
|
11 |
28,419,502
|
March 31, 2024 | USD 17.01 | 1.06% |
|
France |
|
12 |
19,562,147
|
Dec. 31, 2023 | USD 6.79 | 2.49% |
|
France |
|
13 |
18,353,179
|
Dec. 31, 2023 | USD 3.27 | -7.78% |
|
France |
|
14 |
12,898,785
|
Dec. 31, 2023 | USD 2.39 | -7.42% |
|
France |
|
15 |
12,461,987
|
Dec. 31, 2023 | USD 1.42 | 2.06% |
|
France |
|
16 |
11,365,004
|
Dec. 31, 2023 | USD 7.79 | 1.73% |
|
France |
|
17 |
11,080,590
|
Dec. 31, 2023 | USD 5.82 | 3.14% |
|
France |
|
18 |
10,488,178
|
Dec. 31, 2023 | USD 2.07 | 0.33% |
|
France |
|
19 |
3,720,277
|
Dec. 31, 2023 | USD 3.93 | 1.44% |
|
France |
|
20 |
5,044
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
The Clinical Trials company in France with the highest Shares (Diluted, Weighted) is DBV Technologies S.A. (NasdaqCM: DBVT) at 95,121,390.
The Clinical Trials company in France with the lowest Shares (Diluted, Weighted) is Eurofins-Cerep SA (Paris Stock Exchange: ALECR.PA) at 5,044.
The top 10 Clinical Trials companies in France by Shares (Diluted, Weighted) are DBV Technologies S.A., Innate Pharma S.A., Novacyt S.A., AB Science S.A., Genfit S.A., Inventiva S.A., ABIVAX SA, Crossject SA, Nanobiotix S.A. and Affluent Medical SA.
The bottom 10 Clinical Trials companies in France by Shares (Diluted, Weighted) are Eurofins-Cerep SA, Predilife S.A., Advicenne S.A., Adocia SA, MaaT Pharma SA, Valbiotis SA, Aelis Farma SA, Median Technologies SA, OSE Immunotherapeutics SA and MedinCell S.A..